For multi-site regulated manufacturers

ISO 13485 + FDA QMSR readiness, across every site you run

Built for the VP Quality carrying a QMS across three plants, two contract manufacturers, and a clinical site. Not another generic compliance checkbox tool — a defensible mechanism that maps every clause to the controls that enforce it, the evidence that substantiates it, and the effectiveness data that closes the loop.

ClauseControlEvidenceEffectiveness
~6-minute diagnostic
ISO 13485 + QMSR + EU MDR mapped
Inspection-defensible report
The mechanism

One system of record for every clause, across every site

Audit readiness isn't a binder you assemble three weeks before the certification body arrives. It's a mechanism that runs every day.

01
Clause

Every ISO 13485, 21 CFR Part 820, and EU MDR requirement maintained as a single source — not scattered across site binders.

02
Control

Each clause mapped to the procedures, policies, and design controls that enforce it. Ownership assigned per site, per process.

03
Evidence

DHR, DHF, CAPA records, validation reports, training logs — linked to the control they substantiate, with freshness tracking.

04
Effectiveness

Post-market surveillance, CAPA closure metrics, and management review data that proves the control actually works — not just exists.

Step 1 of 520%
When do you need ISO 13485:2016 certification?
We'll tailor your readiness diagnostic to your target timeline.
Is this for you?

Built for multi-site regulated manufacturers — not single-site checklist shops

If any of the below sound like your organisation, the Clause → Control → Evidence → Effectiveness approach is going to feel like oxygen.

Manufacturing across 2+ plants, sites, or contract manufacturers
Dual-market posture: FDA QMSR + ISO 13485, with EU MDR or IVDR on the roadmap
Class I / II / III devices, IVDs, or combination products under active submission
VP Quality, Director of Regulatory, or Head of Compliance owning the multi-site QMS rollout
What QMSR actually changes

The 2026 QMSR transition isn't a paperwork exercise

Four things every medical device QA/RA team needs to reconcile — fast.

QMSR is in effect — and FDA inspectors are already citing it

As of February 2, 2026, 21 CFR Part 820 incorporates ISO 13485:2016 by reference. Teams still running a legacy QSR-only QMS are exposed during Form 483s and inspections.

QMSR ≠ ISO 13485 verbatim — the deltas matter

Labeling, record controls, UDI, complaint files, and management responsibility all have FDA-specific overlays. Mapping ISO clauses to QMSR without the overlay creates blind spots.

Design controls and CAPA remain the top inspection findings

Design History File gaps, ineffective CAPA closures, and weak post-market surveillance are still the #1–#3 observations. Your QMS rewrite has to prove closure, not just process.

MDSAP + EU MDR stack on top

If you need MDSAP or a CE mark alongside US market access, you need one QMS that satisfies ISO 13485, QMSR, MDSAP audit model, and MDR Annex IX — without maintaining four spreadsheets.

What you'll receive

A structured, defensible diagnostic — not a generic ISO score

Every output maps back to clause, control, evidence, and effectiveness across every site you operate.

Combined ISO 13485 + QMSR score

0–100 readiness across core QMS clauses, medical-device-specific requirements (design controls, risk, traceability), and deployment complexity.

Top 5 gaps — ranked for FDA inspection risk

Weakest areas surfaced with clause / 21 CFR §820 subpart references so your remediation roadmap is defensible.

5-phase QMS modernization pathway

Sequenced plan from governance + procedure rewrite → design controls uplift → CAPA effectiveness → PMS/UDI → inspection rehearsal.

30-min readiness call (optional)

Walk through your report with a CertPath specialist. Get a prioritized to-do list and a realistic timeline to inspection readiness.

Stop chasing audits. Build a QMS that stays ready.

Score your multi-site readiness in 6 minutes. Read the tailored report. Then book a 30-min call to translate gaps into a dated, site-by-site remediation plan.

FAQ

Answers before you click start

Does this cover QMSR, not just ISO 13485?
Yes. The ISO 13485 question set maps to the 21 CFR Part 820 revisions that took effect 2 Feb 2026, including labeling (§820.45), record controls (§820.35), UDI requirements, and management responsibility overlays. You get one score that reflects both.
Who is this for?
Medical device manufacturers, contract manufacturers, and specification developers — typically 10–500 employees — whose QA/RA team is pre-certification, post-audit-finding, or mid-transition from legacy QSR.
Do I need to give a work email?
Yes. Reports are delivered only to verified work emails. Personal addresses (gmail, yahoo, outlook.com) and role inboxes are rejected at submission.
How long does it take?
About 6 minutes. ~18 questions tailored to your target standard and deployment context. Your personalized PDF-style report lands in your inbox within 60 seconds.

Already know you want the platform?

Or start a free trial

14-day trial · No credit card · Cancel anytime